DEPATUXIZUMAB MAFODOTIN

UNII: F3R7A4P04N
Preferred Substance Name: DEPATUXIZUMAB MAFODOTIN

1585973-65-4
ABT-414
DEPATUXIZUMAB MAFODOTIN [INN]
DEPATUXIZUMAB MAFODOTIN [JAN]
DEPATUXIZUMAB MAFODOTIN [USAN]
DEPATUXIZUMAB MAFODOTIN [WHO-DD]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN F

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DEPATUXIZUMAB MAFODOTIN

Synonyms and Mappings

Resources

Note